Skip to main content
OpenTrials
Completed

NCT Number: NCT01746407

Procurement of Human Specimens for the Evaluation of Early Markers of Sepsis

Procure blood specimens from individuals presenting to the emergency department (ED) with signs and /or symptoms of systemic infection or sepsis. The samples will be used for research and development activities related to sepsis, infections, etc.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Emory University Hospital, Atlanta, Georgia, United States

Loading trial locations.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • 18 yrs of age or older
  • For women of child bearing years: not known to be pregnant
  • Blood culture ordered as part of the ED, ICU (or equivalent) or hospital floor stay.

Exclusion criteria

  • Previously enrolled in this study
  • Vulnerable individual
  • Unable to speak and/or understand English

Treatment and study plan

Primary outcomes

  1. Progression of infection to severe sepsis

    Time frame: 72 hours

    Assessment of the progression of infection to severe sepsis in an ED population who present with signs or symptoms of infection.

Sponsors and collaborators

Lead sponsor

Abbott Diagnostics Division

Industry

Registry information

Official study title

Observational Study to Procure Human Specimens for Use in the Diagnosis and Management of Sepsis and Other Related Conditions

Acronym: EMOS

Important dates

Study start
2012
Primary completion
2014
Study completion
2014
First posted
Dec 11, 2012
Registry last updated
Dec 30, 2015

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.